Hodgkin’s lymphoma and its association with EBV and HIV infection

References

• Phillips AA, Smith DA. Health disparities and the global landscape of lymphoma care today. Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Meet. 2017;37:526–534.
   PubMedGoogle Scholar
• Zhang L, Ghielmini M, Cheson BD, et al. Pros and cons of rituximab maintenance in follicular lymphoma. Cancer Treatment Rev. 2017;58:34–40.
   PubMed Web of Science ®Google Scholar
• Holzhauser E, Berlin M, Wollschlager D, et al. Patterns of failure of diffuse large B-cell lymphoma patients after involved-site radiotherapy. Strahlenther Onkol. 2017;193:1014–1023.
   PubMed Web of Science ®Google Scholar
• Lee S, Day NS, Miles RR, et al. Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report. Br J Haematol. 2017;177:601–611.
   PubMed Web of Science ®Google Scholar
• Linke-Serinsoz E, Fend F, Quintanilla-Martinez L. Human immunodeficiency virus (HIV) and Epstein–Barr virus (EBV) related lymphomas, pathology view point. Semin Diagn Pathol. 2017;34:352–363.
   PubMed Web of Science ®Google Scholar
• Hohaus S. Genomic imbalances in circulating DNA in Hodgkin's lymphoma. Lancet Haematol. 2015;2:e48–e49.
   PubMed Web of Science ®Google Scholar
• Hohaus S, Giachelia M, Massini G, et al. Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. Ann Oncol. 2009;20:1408–1413.
   PubMed Web of Science ®Google Scholar
• Brune V, Tiacci E, Pfeil I, et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med. 2008;205:2251–2268.
   PubMed Web of Science ®Google Scholar
• Greiner A, Tobollik S, Buettner M, et al. Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma. J Pathol. 2005;205:541–547.
   PubMed Web of Science ®Google Scholar
• Kuppers R. Molecular biology of Hodgkin lymphoma. Hematol Am Soc Hematol Educ Prog. 2009;491–496. DOI:10.1182/asheducation-2009.1.491
   PubMedGoogle Scholar
• Kuppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer. 2009;9:15–27.
   PubMed Web of Science ®Google Scholar
• Ebrahim EK, Assem MM, Amin AI, et al. FLT3 internal tandem duplication mutation, cMPL and CD34 expressions predict low survival in acute myeloid leukemia patients. Ann Clin Lab Sci. 2016;46:592–600.
   PubMed Web of Science ®Google Scholar
• De Souza A, Ferry JA, Burghart DR, et al. IgG4 expression in primary cutaneous marginal zone lymphoma: a multicenter study. Appl Immunohistochem Mol Morphol. 2017 [cited Feb 1]. DOI:10.1097/PAI.0000000000000462
   Google Scholar
• Kuppers R, Rajewsky K, Zhao M, et al. Hodgkin disease: Hodgkin and Reed–Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA. 1994;91:10962–10966.
   PubMed Web of Science ®Google Scholar
• Kuppers R, Kanzler H, Hansmann ML, et al. Single cell analysis of Hodgkin/Reed–Sternberg cells. Ann Oncol. 1996;7:27–30.
   PubMed Web of Science ®Google Scholar
• Kanzler H, Hansmann ML, Kapp U, et al. Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed–Sternberg cells of a Hodgkin's lymphoma patient. Blood. 1996;87:3429–3436.
   PubMed Web of Science ®Google Scholar
• Kuppers R, Kanzler H, Hansmann ML, et al. Immunoglobulin V genes in Reed–Sternberg cells. N Engl J Med. 1996;334:404.
   PubMedGoogle Scholar
• Kanzler H, Kuppers R, Hansmann ML, et al. Hodgkin and Reed–Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184:1495–1505.
   PubMed Web of Science ®Google Scholar
• Hutchings M, Loft A, Hansen M, et al. Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake. Hematol Oncol. 2006;24:146–150.
   PubMed Web of Science ®Google Scholar
• Marafioti T, Hummel M, Anagnostopoulos I, et al. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. JCO. 1999;17:3804–3809.
   PubMed Web of Science ®Google Scholar
• Martin-Subero JI, Kreuz M, Bibikova M, et al. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood. 2009;113:2488–2497.
   PubMed Web of Science ®Google Scholar
• Schumacher MA, Schmitz R, Brune V, et al. Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma. Haematologica. 2010;95:153–157.
   PubMed Web of Science ®Google Scholar
• Eckerle S, Brune V, Doring C, et al. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma. Leukemia. 2009;23:2129–2138.
   PubMed Web of Science ®Google Scholar
• Willenbrock K, Kuppers R, Renne C, et al. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. Haematologica. 2006;91:596–604.
   PubMed Web of Science ®Google Scholar
• Steidl C. Exposing Hodgkin–Reed–Sternberg cells. Blood. 2017;129:6–7.
   PubMed Web of Science ®Google Scholar
• Reichel JB, McCormick J, Fromm JR, et al. Flow-sorting and exome sequencing of the Reed–Sternberg cells of classical Hodgkin lymphoma. J Visual Exp. 2017 [cited Jun 10]. DOI:10.3791/54399
   PubMed Web of Science ®Google Scholar
• Grewal R, Cucuianu A, Swanepoel C, et al. The role of microRNAs in the pathogenesis of HIV-related lymphomas. Crit Rev Clin Lab Sci. 2015;52:232–241.
   PubMed Web of Science ®Google Scholar
• Vanky F, Wang P, Klein E. The polysaccharide K (PSK) potentiates in vitro activation of the cytotoxic function in human blood lymphocytes by autologous tumour cells. Cancer Immunol Immunother. 1992;35:193–198.
   PubMed Web of Science ®Google Scholar
• Schwering I, Brauninger A, Distler V, et al. Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes. Mol Med. 2003;9:85–95.
   PubMed Web of Science ®Google Scholar
• Tinguely M, Rosenquist R, Sundstrom C, et al. Analysis of a clonally related mantle cell and Hodgkin lymphoma indicates Epstein–Barr virus infection of a Hodgkin/Reed–Sternberg cell precursor in a germinal center. Am J Surg Pathol. 2003;27:1483–1488.
   PubMed Web of Science ®Google Scholar
• Brauninger A, Spieker T, Mottok A, et al. Epstein–Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes. Eur J Immunol. 2003;33:1593–1602.
   PubMed Web of Science ®Google Scholar
• Brauninger A, Spieker T, Willenbrock K, et al. Survival and clonal expansion of mutating “forbidden” (immunoglobulin receptor-deficient) Epstein–Barr virus-infected b cells in angioimmunoblastic t cell lymphoma. J Exp Med. 2001;194:927–940.
   PubMed Web of Science ®Google Scholar
• Seliem RM, Chikwava K, Swerdlow SH, et al. Classical Hodgkin's lymphoma presenting as a testicular mass: report of a case. Int J Surg Pathol. 2007;15:207–212.
   PubMed Web of Science ®Google Scholar
• Enciso-Mora V, Broderick P, Ma Y, et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet. 2010;42:1126–1130.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Meisner D, Talreja N, et al. Classical nodular sclerosis Hodgkin lymphoma presenting with central nervous system disease. South Med J. 2007;100:549–550.
   PubMed Web of Science ®Google Scholar
• Viviani S, Tabanelli V, Pileri SA. The pathobiology and treatment of Hodgkin lymphoma. Where do we go from Gianni Bonadonna's lesson? TJ. 2017;103:101–113.
   Google Scholar
• Benharroch D, Einav I, Feldman A, et al. Apoptosis of Hodgkin–Reed–Sternberg cells in classical Hodgkin lymphoma revisited. APMIS. 2010;118:339–345.
   PubMed Web of Science ®Google Scholar
• Hartmann S, Martin-Subero JI, Gesk S, et al. Detection of genomic imbalances in microdissected Hodgkin and Reed–Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization. Haematologica. 2008;93:1318–1326.
   PubMed Web of Science ®Google Scholar
• Eberle FC, Mani H, Jaffe ES. Histopathology of Hodgkin's lymphoma. Cancer J. 2009;15:129–137.
   PubMed Web of Science ®Google Scholar
• Mani H, Jaffe ES. Hodgkin lymphoma: an update on its biology with new insights into classification. Clin Lymphoma Myeloma. 2009;9:206–216.
   PubMedGoogle Scholar
• Rautert R, Schinkothe T, Franklin J, et al. Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma. Leuk Lymphoma. 2008;49:2091–2098.
   PubMed Web of Science ®Google Scholar
• Kumar V. Robbins and Cotran: pathologic basis of disease. In: International tE, editor. Saunders: Elsevier; 2010.
   Google Scholar
• Zhang XM, Aguilera N. New immunohistochemistry for B-cell lymphoma and Hodgkin lymphoma. Arch Pathol Lab Med. 2014;138:1666–1672.
   PubMed Web of Science ®Google Scholar
• O'Malley DP, Fedoriw Y, Weiss LM. Distinguishing classical Hodgkin lymphoma, gray zone lymphoma, and large B-cell lymphoma: a proposed scoring system. Appl Immunohistochem Mol Morphol: AIMM. 2016;24:535–540.
   PubMed Web of Science ®Google Scholar
• Scott DW, Steidl C. The classical Hodgkin lymphoma tumor microenvironment: macrophages and gene expression-based modeling. Hematol Am Soc Hematol Educ Prog. 2014;2014:144–150.
   PubMedGoogle Scholar
• Pina-Oviedo S, Moran CA. Primary mediastinal classical Hodgkin lymphoma. Adv Anat Pathol. 2016;23:285–309.
   PubMed Web of Science ®Google Scholar
• Jain A, Gupta N. Primary Hodgkin's lymphoma of the sternum: report of a case and review of the literature. J Clin Diagn Res: JCDR. 2016;10:XE07–XE10.
   PubMed Web of Science ®Google Scholar
• Dunleavy K, Grant C, Eberle FC, et al. Gray zone lymphoma: better treated like Hodgkin lymphoma or mediastinal large B-cell lymphoma? Curr Hematol Malig Rep. 2012;7:241–247.
   PubMed Web of Science ®Google Scholar
• Pervez S, Khawaja RD. Mediastinal lymphomas: primary mediastinal (thymic) large B-cell lymphoma versus classical Hodgkin lymphoma, histopathologic dilemma solved? Pathol Res Pract. 2010;206:365–367.
   PubMed Web of Science ®Google Scholar
• Gloghini A, Bosco A, Ponzoni M, et al. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications. Expert Rev Hematol. 2015;8:217–223.
   PubMed Web of Science ®Google Scholar
• Vose JM. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management. Am J Hematol. 2017;92:806–813.
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Beltran BE, Miranda RN, et al. EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016;91:529–537.
   PubMed Web of Science ®Google Scholar
• Tomuleasa C, Zaharie F, Muresan MS, et al. How to diagnose and treat a cancer of unknown primary site. J Gastrointestin Liver Dis. 2017;26:69–79.
   PubMed Web of Science ®Google Scholar
• Bain BJ. The haematologist and the infective complications of HIV infection. Hematology. 1998;3:153–164.
   PubMedGoogle Scholar
• Bain BJ. Diagnosis from the blood smear. N Engl J Med. 2005;353:498–507.
   PubMed Web of Science ®Google Scholar
• Hernandez AM. Peripheral blood manifestations of lymphoma and solid tumors. Clin Lab Med. 2002;22:215–252.
   PubMed Web of Science ®Google Scholar
• Leonard JP, Martin P, Roboz GJ. Practical implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia. JCO. 2017;35:2708–2715.
   PubMed Web of Science ®Google Scholar
• Franco V, Tripodo C, Rizzo A, et al. Bone marrow biopsy in Hodgkin's lymphoma. Eur J Haematol. 2004;73:149–155.
   PubMed Web of Science ®Google Scholar
• Chang KC, Khen NT, Jones D, et al. Epstein–Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype. Hum Pathol. 2005;36:747–755.
   PubMed Web of Science ®Google Scholar
• Kutok JL, Wang F. Spectrum of Epstein–Barr virus-associated diseases. Annu Rev Pathol Mech Dis. 2006;1:375–404.
   PubMed Web of Science ®Google Scholar
• Shannon-Lowe C, Rickinson AB, Bell AI. Epstein–Barr virus-associated lymphomas. Phil Trans R Soc B Biol Sci. 2017;372:20160271. DOI:10.1098/rstb.2016.0271
   PubMed Web of Science ®Google Scholar
• Chanut A, Duguet F, Marfak A, et al. RelA and RelB cross-talk and function in Epstein–Barr virus transformed B cells. Leukemia. 2014;28:871–879.
   PubMed Web of Science ®Google Scholar
• Roschewski M, Wilson WH. Lymphomatoid granulomatosis. Cancer J. 2012;18:469–474.
   PubMed Web of Science ®Google Scholar
• Eliopoulos AG, Waites ER, Blake SM, et al. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein–Barr virus-encoded latent infection membrane protein 1 but not CD40. J Virol. 2003;77:1316–1328.
   PubMed Web of Science ®Google Scholar
• Brauninger A, Schmitz R, Bechtel D, et al. Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma. Int J Cancer. 2006;118:1853–1861.
   PubMed Web of Science ®Google Scholar
• Carbone A, Gloghini A. Activated DDR1 increases RS cell survival. Blood. 2013;122:4152–4154.
   PubMed Web of Science ®Google Scholar
• Kuppers R. Clonotypic B cells in classic Hodgkin lymphoma. Blood. 2009;114:3970–3971.
   PubMed Web of Science ®Google Scholar
• Renne C, Willenbrock K, Martin-Subero JI, et al. High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma. Leukemia. 2007;21:780–787.
   PubMed Web of Science ®Google Scholar
• Chaganti S, Bell AI, Pastor NB, et al. Epstein–Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes. Blood. 2005;106:4249–4252.
   PubMed Web of Science ®Google Scholar
• Dhiab MB, Ziadi S, Mestiri S, et al. DNA methylation patterns in EBV-positive and EBV-negative Hodgkin lymphomas. Cell Oncol. 2015;38:453–462.
   Web of Science ®Google Scholar
• Siemer D, Kurth J, Lang S, et al. EBV transformation overrides gene expression patterns of B cell differentiation stages. Mol Immunol. 2008;45:3133–3141.
   PubMed Web of Science ®Google Scholar
• Mancao C, Altmann M, Jungnickel B, et al. Rescue of “crippled” germinal center B cells from apoptosis by Epstein–Barr virus. Blood. 2005;106:4339–4344.
   PubMed Web of Science ®Google Scholar
• Giulino L, Mathew S, Ballon G, et al. A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma. Blood. 2011;117:4852–4854.
   PubMed Web of Science ®Google Scholar
• Schmitz R, Hansmann ML, Bohle V, et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med. 2009;206:981–989.
   PubMed Web of Science ®Google Scholar
• Leonard S, Wei W, Anderton J, et al. Epigenetic and transcriptional changes which follow Epstein–Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma. J Virol. 2011;85:9568–9577.
   PubMed Web of Science ®Google Scholar
• Biggar RJ, Jaffe ES, Goedert JJ, et al. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood. 2006;108:3786–3791.
   PubMed Web of Science ®Google Scholar
• Brenchley JM, Ruff LE, Casazza JP, et al. Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo. J Virol. 2006;80:6801–6809.
   PubMed Web of Science ®Google Scholar
• Zoufaly A, Stellbrink HJ, Heiden MA, et al. Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma. J Infect Dis. 2009;200:79–87.
   PubMed Web of Science ®Google Scholar
• Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008;123:187–194.
   PubMed Web of Science ®Google Scholar
• Hoffmann CJ, Gallant JE. Rationale and evidence for human immunodeficiency virus treatment as prevention at the individual and population levels. Infect Dis Clin N Am. 2014;28:549–561.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008.
   Google Scholar
• Chetty M, Sudi S, Abayomi EA. Prevalence and spectrum of head and neck lymphomas at Tygerberg Hospital, South Africa, 2003 to 2007. SADJ. 2012;67:270, 2–4, 6–7.
   PubMedGoogle Scholar
• Biggar RJ, Chaturvedi AK, Goedert JJ, et al. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99:962–972.
   PubMed Web of Science ®Google Scholar
• Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425–432.
   PubMed Web of Science ®Google Scholar
• Grogg KL, Miller RF, Dogan A. HIV infection and lymphoma. J Clin Pathol. 2007;60:1365–1372.
   PubMed Web of Science ®Google Scholar
• Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385:977–1010.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, et al. Cancer in Africa 2012. Cancer Epidemiol Biomark Prev. 2014;23:953–966.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Forman D, et al. Cancer burden in Africa and opportunities for prevention. Cancer. 2012;118:4372–4384.
   PubMed Web of Science ®Google Scholar
• Znaor A, van den Hurk C, Primic-Zakelj M, et al. Cancer incidence and mortality patterns in South Eastern Europe in the last decade: gaps persist compared with the rest of Europe. Eur J Cancer. 2013;49:1683–1691.
   PubMed Web of Science ®Google Scholar
• Georgakis MK, Papathoma P, Ryzhov A, et al. Malignant central nervous system tumors among adolescents and young adults (15–39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: mortality and survival patterns. Cancer. 2017;123:4458–4471.
   PubMed Web of Science ®Google Scholar
• Georgakis MK, Karalexi MA, Agius D, et al. Incidence and time trends of childhood lymphomas: findings from 14 Southern and Eastern European cancer registries and the Surveillance, Epidemiology and End Results, USA. Cancer Causes Control. 2016;27:1381–1394.
   PubMed Web of Science ®Google Scholar
• Fetica B, Achimas-Cadariu P, Pop B, et al. Non-Hodgkin lymphoma in Romania: a single-centre experience. Hematol Oncol. 2017;35:198–205.
   PubMed Web of Science ®Google Scholar
• Zanetti R, Schmidtmann I, Sacchetto L, et al. Completeness and timeliness: cancer registries could/should improve their performance. Eur J Cancer. 2015;51:1091–1098.
   PubMed Web of Science ®Google Scholar
• Patel M, Philip V, Fazel F. Human immunodeficiency virus infection and Hodgkin's lymphoma in South Africa: an emerging problem. Adv Hematol. 2011;2011:578163.
   PubMedGoogle Scholar
• Wiggill TM, Mantina H, Willem P, et al. Changing pattern of lymphoma subgroups at a tertiary academic complex in a high-prevalence HIV setting: a South African perspective. J Acquir Immune Deficiency Syndromes. 2011;56:460–466.
   PubMed Web of Science ®Google Scholar
• Ayers LW, Silver S, McGrath MS, et al. The AIDS and cancer specimen resource: role in HIV/AIDS scientific discovery. Infect Agents Cancer. 2007;2:7.
   PubMedGoogle Scholar
• Davidson A, Wainwright RD, Stones DK, et al. Malignancies in South African children with HIV. J Pediatr Hematol Oncol. 2014;36:111–117.
   PubMed Web of Science ®Google Scholar
• Chokunonga E, Borok MZ, Chirenje ZM, et al. Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010. Int J Cancer. 2013;133:721–729.
   PubMed Web of Science ®Google Scholar
• Tanon A, Jaquet A, Ekouevi DK, et al. The spectrum of cancers in West Africa: associations with human immunodeficiency virus. PLoS One. 2012;7:e48108.
   PubMed Web of Science ®Google Scholar
• Oluwasola AO, Olaniyi JA, Otegbayo JA, et al. A fifteen-year review of lymphomas in a Nigerian tertiary healthcare centre. J Health Popul Nutr. 2011;29:310–316.
   PubMed Web of Science ®Google Scholar
• Olu-Eddo AN, Omoti CE. Hodgkin lymphoma: clinicopathologic features in Benin City, Nigeria and update on its biology and classification. Niger J Clin Pract. 2011;14:440–444.
   PubMed Web of Science ®Google Scholar
• Naresh KN, Raphael M, Ayers L, et al. Lymphomas in sub-Saharan Africa – what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research? Br J Haematol. 2011;154:696–703.
   PubMed Web of Science ®Google Scholar
• Bolarinwa RA, Ndakotsu MA, Oyekunle AA, et al. AIDS-related lymphomas in Nigeria. Braz J Infect Dis. 2009;13:359–361.
   PubMed Web of Science ®Google Scholar
• Bower M, Newsom-Davis T, Naresh K, et al. Clinical features and outcome in HIV-associated multicentric Castleman's disease. JCO. 2011;29:2481–2486.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.
   PubMed Web of Science ®Google Scholar
• Reddy DL, Venter WD, Pather S. Patterns of lymph node pathology; fine needle aspiration biopsy as an evaluation tool for lymphadenopathy: a retrospective descriptive study conducted at the largest hospital in Africa. PLoS One. 2015;10:e0130148.
   PubMed Web of Science ®Google Scholar
• Alli N, Meer S. Head and neck lymphomas: a 20-year review in an Oral Pathology Unit, Johannesburg, South Africa, a country with the highest global incidence of HIV/AIDS. Oral Oncol. 2017;67:17–23.
   PubMed Web of Science ®Google Scholar
• Abayomi EA, Somers A, Grewal R, et al. Impact of the HIV epidemic and anti-retroviral treatment policy on lymphoma incidence and subtypes seen in the Western Cape of South Africa, 2002–2009: preliminary findings of the Tygerberg Lymphoma Study Group. Transfus Apheresis Sci. 2011;44:161–166.
   PubMed Web of Science ®Google Scholar
• Mantina H, Wiggill TM, Carmona S, et al. Characterization of lymphomas in a high prevalence HIV setting. J Acquir Immune Deficiency Syndromes. 2010;53:656–660.
   PubMed Web of Science ®Google Scholar
• Stein L, Urban MI, O'Connell D, et al. The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995–2004. Int J Cancer. 2008;122:2260–2265.
   PubMed Web of Science ®Google Scholar
• Westmoreland KD, Stanley CC, Montgomery ND, et al. Hodgkin lymphoma, HIV, and Epstein–Barr virus in Malawi: longitudinal results from the Kamuzu Central Hospital Lymphoma study. Pediatr Blood Cancer. 2017;64:e26302. DOI:10.1002/pbc.26302
   Web of Science ®Google Scholar